Edwards Lifesciences Fined $10M for Antitrust Violations in JC Medical Acquisition
Edwards Lifesciences has agreed to a $10 million penalty after violating antitrust laws by structuring its acquisition of JC Medical to avoid mandatory HSR Act review. The FTC claims the deal reduced competition and led to hospital consolidation.
Tickers: $EW
Topics: acquisition antitrust law FTC medical devices